Literature DB >> 1566318

Poliomyelitis outbreak in Natal/KwaZulu, South Africa, 1987-1988. 2. Immunity aspects.

B D Schoub1, S Johnson, J M McAnerney, A van Middelkoop, H G Kustner, I Windsor, C Vinsen, K McDonald.   

Abstract

An extensive poliomyelitis outbreak due to type 1 poliovirus took place in Natal/KwaZulu, South Africa, in 1987-1988, causing 412 paralytic cases. This epidemic differed from a previously described outbreak in Gazankulu, South Africa, in 1982 in that it occurred against a background of relatively good immunity. Thus, only 12% of patients lacked antibodies to types 2 and 3, indicating lack of previous immunization, and 76% of healthy children sampled in the epidemic area had serological immunity to all 3 types of poliovirus. The occurrence of extensive outbreaks in relatively well-immunized communities emphasizes the need to maximize herd immunity and reduce reservoirs of infection in the gut and in the environment, which can be achieved only with oral polio vaccine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566318     DOI: 10.1016/0035-9203(92)90453-j

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.

Authors:  R W Linkins; E Mansour; O Wassif; M H Hassan; P A Patriarca
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

2.  Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.

Authors:  Joseph Kl Opare; Patricia Akweongo; Edwin A Afari; John K Odoom
Journal:  Ghana Med J       Date:  2019-06

Review 3.  Causes of impaired oral vaccine efficacy in developing countries.

Authors:  Edward Pk Parker; Sasirekha Ramani; Benjamin A Lopman; James A Church; Miren Iturriza-Gómara; Andrew J Prendergast; Nicholas C Grassly
Journal:  Future Microbiol       Date:  2017-12-08       Impact factor: 3.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.